CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG [Phase 2]
Summary
The Phase 2 pilot study of CT1812 in mild-to-moderate Alzheimer disease using EEG has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cognition Therapeutics | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-11-29